3651 results for «521»
3651 results
Diversity in coronary artery disease treatment
22 May 2026 – From EuroPCR 2026
Focusing on the diversity in coronary artery disease treatment, this session highlights challenges ranging from maintaining interventional cardiology services during conflict to the influence of comorbidities such as type 2 diabetes mellitus on prognosis and risk assessment. It also presents clinical outcomes related to stent thrombosis...
Complex coronary artery intervention: how DCB can help us
21 May 2026 – From EuroPCR 2026
This session delves into the role of Drug-Coated Balloons (DCB) in managing complex coronary artery interventions. It covers DCB-based PCI approaches in challenging lesions, compares clinical outcomes between Paclitaxel-coated balloon-only PCI and other strategies, and evaluates the effectiveness of DCB versus Drug-Eluting Stents (DES) in de...
Complication management in CTO PCI - Part 2
22 May 2026 – From EuroPCR 2026
This session focuses on managing complications during chronic total occlusion (CTO) PCI procedures. It presents challenging cases including artery perforations, donor vessel-related procedural difficulties, and intramural hematoma rescue guided by intravascular ultrasound (IVUS). Strategies to address in-stent CTO and the unpredictable nature of CTO PCI complications...
Nightmare scenarios in the cathlab
21 May 2026 – From EuroPCR 2026
This session presents challenging and unexpected scenarios encountered in the catheterisation laboratory, highlighting critical complications such as stent-induced coronary dissections, acute arterial occlusions, and procedural catastrophes. Real-life cases illustrate emergency management strategies, including rescue techniques for vascular complications and early recognition of acute syndromes, underscoring the...
Left main PCI-complex procedures
22 May 2026 – From EuroPCR 2026
This session covers complex left main coronary artery PCI procedures that challenge standard algorithms. It includes tackling chronic total occlusions of the left main, managing spontaneous coronary artery dissection in patients on ECMO, handling stent dislodgement, and addressing complex trifurcation lesions, providing comprehensive insights into advanced...
CT and intracoronary imaging evaluation of coronary disease
21 May 2026 – From EuroPCR 2026
This session focuses on advanced imaging modalities for evaluating coronary artery disease, including the clinical application of CT angiography and intracoronary imaging techniques like OCT and IVUS. Topics encompass barriers to OCT usage, the impact of plaque composition on PCI outcomes, advances in photon-counting CT technology,...
Calcified lesions: when one dedicated device is not enough
22 May 2026 – From EuroPCR 2026
This session highlights the need for multiple dedicated devices in the treatment of calcified coronary lesions. It discusses combined orbital and rotational atherectomy techniques, debulking in complex high-risk patients, and the integration of atherectomy with intravascular lithotripsy systems. Emphasis is placed on physiology and imaging-guided approaches...
Left main PCI
21 May 2026 – From EuroPCR 2026
This session addresses the complexities of percutaneous coronary intervention (PCI) involving the left main coronary artery. It features challenging clinical cases including acute total occlusion with cardiogenic shock, innovative techniques like the inverted Double TAP for trifurcations, mechanical circulatory support integration, management of stent complications, and...
TAVI procedural challenges
21 May 2026 – From EuroPCR 2026
This session examines procedural challenges encountered during Transcatheter Aortic Valve Implantation (TAVI), especially in complex anatomical and clinical contexts. Topics include TAVI after prior mitral valve procedures, combined use of left ventricular assist devices and rotablation, navigating challenging aortic anatomies, and managing extensive calcification. The session...
Innovative strategies in STEMI management
22 May 2026 – From EuroPCR 2026
This session presents innovative strategies in STEMI management, including the treatment of acute saphenous vein graft occlusion, primary PCI via the left internal mammary artery, and a two-step lesion debulking approach. It also covers hybrid drug-coated balloon strategies in complex multivessel disease and the emerging role...
Challenging cases in calcified lesions PCI
22 May 2026 – From EuroPCR 2026
This session addresses challenging cases in PCI of heavily calcified lesions. It covers unexpected complications such as silent shockwave failures, interventions in calcified Kawasaki disease, delayed coronary obstructions post-TAVI, and complex left main bifurcation lesions. The session underscores the perseverance required to successfully navigate these demanding...
TAVI sub-studies - Beyond the primary endpoint
21 May 2026 – From EuroPCR 2026
This session reviews key sub-studies from major TAVI trials that extend beyond primary endpoints to provide a deeper understanding of valve performance and patient outcomes. It covers comparisons between balloon-expandable and self-expanding valves, long-term real-world data on the Myval valve, echocardiographic outcomes, composite endpoint analyses, and...
Challenges of multivessel disease in ACS
21 May 2026 – From EuroPCR 2026
Dedicated to the challenges of multivessel disease in acute coronary syndrome (ACS), this session explores strategies to identify culprit versus non-culprit lesions and plan multivessel revascularisation using physiology, intravascular imaging, and artificial intelligence. It further discusses the timing considerations for revascularisation, whether ad-hoc or staged, illustrated...
From wires to knives: CABG essentials every cathlab nurse and allied professional should know
21 May 2026 – From EuroPCR 2026
This session is designed to equip cathlab nurses and allied professionals with essential knowledge about Coronary Artery Bypass Grafting (CABG). It covers the indications for CABG, relevant cardiovascular anatomy and physiology, and the importance of effective communication with patients undergoing CABG procedures. Practical walkthroughs of angiograms...
Spotlight - TAVI durability: contemporary evidence and future directions
21 May 2026 – From EuroPCR 2026
Focusing on TAVI durability, this session reviews recent clinical evidence from randomized trials and large registries, examining procedural and device-related factors influencing long-term valve performance. It also discusses challenges in follow-up and implications for future trial designs and device monitoring.
When to best combine guided-directed medical therapy and devices at discharge of acute heart failure
20 May 2026 – From EuroPCR 2026
This session addresses the challenges and strategies in optimizing guided-directed medical therapy for acute heart failure patients, especially those intolerant to up-titration. It also covers the assessment and timing for cardiac resynchronisation therapy (CRT), highlighting the benefits of combining medical therapy and device implantation to improve...
Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access
20 May 2026 – From EuroPCR 2026
This session investigates the boundaries of transfemoral access for TAVI and strategies to safely extend its use. It also provides a comprehensive review of facilitated transfemoral TAVI techniques and explores alternative access options, offering critical insights for managing challenging TAVI cases.
TAVI: head-to-head trials
20 May 2026 – From EuroPCR 2026
This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...
New devices for structural interventions
20 May 2026 – From EuroPCR 2026
Explore the latest advancements in structural interventions with a focus on novel devices and their early clinical outcomes. This session reviews cutting-edge technologies including balloon-expandable TAVI, percutaneous mechanical aspiration for infective endocarditis, and emerging transcatheter tricuspid valve replacement systems, alongside multicenter evaluations of TEER devices in...
New data in DCB outcomes
20 May 2026 – From EuroPCR 2026
Explore emerging evidence on drug-coated balloon (DCB) outcomes, featuring intravascular lithotripsy combined with DCB in calcified small vessels, OCT-guided PCI registries, predictors of angiographic success post-sirolimus-coated balloon angioplasty, and clinical impact in multivessel coronary artery disease management.
